Abstract | INTRODUCTION: AREAS COVERED: EXPERT OPINION: Although introduction of novel drugs have improved patients' survival, there is a need to investigate the mechanisms of resistance further. The role of truncated AR and compensatory activation of signaling pathways as well as the development of scientifically justified combination therapies seems to be issues of a high priority.
|
Authors | Zoran Culig |
Journal | Expert opinion on pharmacotherapy
(Expert Opin Pharmacother)
Vol. 15
Issue 10
Pg. 1427-37
(Jul 2014)
ISSN: 1744-7666 [Electronic] England |
PMID | 24890318
(Publication Type: Journal Article, Review)
|
Chemical References |
- 1,7-bis(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one
- AR protein, human
- Androgen Antagonists
- Anilides
- Antibodies, Neutralizing
- Anticarcinogenic Agents
- Antineoplastic Agents
- Benzamides
- HSP90 Heat-Shock Proteins
- Histone Deacetylase Inhibitors
- Nitriles
- Oligonucleotides, Antisense
- Receptors, Androgen
- Tosyl Compounds
- Phenylthiohydantoin
- hydroxyflutamide
- Flutamide
- enzalutamide
- bicalutamide
- CYP17A1 protein, human
- Steroid 17-alpha-Hydroxylase
- Curcumin
|
Topics |
- Androgen Antagonists
(therapeutic use)
- Anilides
(therapeutic use)
- Antibodies, Neutralizing
(therapeutic use)
- Anticarcinogenic Agents
(therapeutic use)
- Antineoplastic Agents
(therapeutic use)
- Benzamides
- Cell Line, Tumor
- Curcumin
(analogs & derivatives, therapeutic use)
- Flutamide
(analogs & derivatives, therapeutic use)
- HSP90 Heat-Shock Proteins
(antagonists & inhibitors)
- Histone Deacetylase Inhibitors
(therapeutic use)
- Humans
- Male
- Molecular Targeted Therapy
- Nitriles
(therapeutic use)
- Oligonucleotides, Antisense
(therapeutic use)
- Phenylthiohydantoin
(analogs & derivatives, therapeutic use)
- Phosphatidylinositol 3-Kinases
(metabolism)
- Prostatic Neoplasms
(drug therapy, metabolism)
- Receptors, Androgen
(metabolism)
- Signal Transduction
- Steroid 17-alpha-Hydroxylase
(antagonists & inhibitors)
- Tosyl Compounds
(therapeutic use)
|